glp 1 physiology GLP-1 Glucagon-Like Peptide-1 Based Therapies: A

29 Another valuable study would be a prospective randomized clinical trial with well-designed primary ocular outcomes comparing the GLP-1/GIP agonists to another diabetes drug class, such as the SLGT inhibitors, which has the same target hemoglobin A1c reduction in both treatment arms

Although the FDA has not approved it specifically for weight loss, research indicates that it may support weight reduction

I will say, Mike, that you did talk about earlier that its in Mens Health and all that

J Chiropr Med

Berdugo-Vega G, Arias-Gil G, Lpez-Fernndez A, Artegiani B, Wasielewska JM, Lee C-C, et al

Psychiatry 29 , 211220 (2024)